TipRanks
NFL Biosciences SA (DE:82F)
FRANKFURT:82F
Germany Market

NFL Biosciences SA (82F) Income Statement

1 Followers

NFL Biosciences SA Income Statement

Last quarter (Q4 2025), NFL Biosciences SA's total revenue was €0.00, a decrease of ― from previous quarter. In Q4, NFL Biosciences SA's net income was €-1.51M. See NFL Biosciences SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 0.00€ 46.00€ 200.01K€ 0.00€ 39.00
Gross Profit
€ -2.52M€ -67.14K€ -56.06K€ -2.24M€ -530.73K
Operating Expenses
€ 1.35M€ 2.72M€ 4.37M€ 668.96K€ 371.17K
Depreciation and Amortization
€ 86.40K€ 67.14K€ 56.06K€ 52.44K€ 43.50K
EBITDA
€ -3.79M€ -2.65M€ -4.05M€ -2.81M€ -1.08M
Operating Income
€ -3.87M€ -2.79M€ -4.43M€ -3.01M€ -901.87K
Other Income/Expenses
€ 14.88K€ 73.84K€ 318.55K€ 152.22K€ -217.64K
Pretax Income
€ -3.86M€ -2.72M€ -4.11M€ -2.86M€ -1.12M
Net Income
€ -3.32M€ -2.08M€ -3.75M€ -2.44M€ -978.24K
Per Share Metrics
Basic EPS
€ -0.26€ -0.21€ -0.46€ -0.47€ -0.19
Diluted EPS
€ -0.26€ -0.21€ -0.46€ -0.47€ -0.19
Weighted Average Shares Outstanding
12.67M 9.83M 8.11M 5.23M 5.23M
Weighted Average Shares Outstanding (Diluted)
12.67M 9.83M 8.11M 5.23M 5.23M
Currency in EUR

NFL Biosciences SA Earnings and Revenue History